tetramethylpyrazine has been researched along with Psoriasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Chen, X; Jiang, R; Liu, J; Wang, Y; Xu, J; Yin, M; Zhang, Y | 1 |
1 other study(ies) available for tetramethylpyrazine and Psoriasis
| Article | Year |
|---|---|
Ligustrazine alleviates psoriasis-like inflammation through inhibiting TRAF6/c-JUN/NFκB signaling pathway in keratinocyte.
Topics: Inflammation; Keratinocytes; Ligusticum; NF-kappa B; Psoriasis; Pyrazines; Signal Transduction; TNF Receptor-Associated Factor 6 | 2022 |